Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients

NCT05229575 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.

NCT NCT05229575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05229575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
Lead sponsor
Campus Bio-Medico University
Phase
Not applicable
Overall status
Unknown status
Start date
July 10, 2020
Completion date
April 10, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv breast cancer